Table 1.
Reference | Gene | Physiologic function | SNP identifier | Associations with clinical outcomes |
---|---|---|---|---|
Reeves-Daniel et al36Freedman et al37,38 | ApoL1 | Trypanosome killing function | rs71785313rs60910145rs73885319 | Reduced kidney allograft survival |
Tonnerre et al47Rohn et al48 | MICA | Stress-induced protein regulated at the cell surface | rs2596538rs67841474 | Anti-MICA sensitization and increased proteinuria in kidney transplant recipients and is a predictor of susceptibility to CMV infection |
Eikmans et al52 | TLR3 | Cell-bound receptor involved in innate immune system | rs3775296 | Increased acute kidney allograft rejection |
Hwang et al64 | TLR4 | Binds to endogenous ligands released from damaged tissues and exogenous ligands such as lipopolysaccharide | rs10759932 | Increased rejection-free survival rate |
Eikmans et al52 | FCN2 | Soluble recognition molecule that can engage apoptotic and necrotic cells | rs7851696 | Reduced incidence of severe kidney allograft rejection and graft loss |
Steers et al56 | LIMS1 | A minor histocompatibility antigen | rs893403 | Increased kidney allograft rejection |
Oetting et al27 | MIR146A | Modulated Treg and suppression of inflammatory responses | rs2910164 | Increased kidney allograft rejection |
Moore et al51 | CAV1 | Involved in cholesterol transport and transmembrane signaling | rs4730751 | Increased kidney allograft failure |
Forconi et al58 | PD-1 | Involved in the dysfunction of HIV-specific T cell response and CMV-specific CD8 T cells | rs11568821 | Improved kidney allograft survival in recipients from CMV-positive donors |
Vu et al59 | IFN-γ | Involved in immune response to viral and bacterial infections | rs2430561 | Increased risk for the CMV infection |
Moore et al49Woillard et al50 | ABCB1 | An efflux pump for intestinal transport of medications including tacrolimus | rs1045642rs2229109 | Increased risk of renal allograft loss |
Dessing et al60 | NLRP3 | NOD-like receptor family, pyrin domain containing 3 is a member of inflammasome family with a causal role in several inflammatory disorders | rs35829419rs6672995 | Increased acute kidney allograft rejection with rs35829419 andReduced acute kidney allograft rejection with rs6672995 |
Abdi et al61Cha et al62 | CCR5 | Chemokine receptor specific for the proinflammatory chemokines | rs1799987 | Increased acute kidney allograft rejection |
Abdi et al61Cha et al62 | CCR2 | Involved in immune response including monocyte recruitment and T cell proliferation | rs1799864 | Increased acute kidney allograft rejection |
Park et al65 | IL2RB | Stimulating T-cell proliferation through complex of IL2RA-IL2RB-IL2 | rs228942rs228953 | Increased acute kidney allograft rejection episodes |
Marshall et al66 | IL6 | A pleiotropic cytokine with proinflammatory and anti-inflammatory properties | rs1800795 | Increased acute kidney allograft rejection |
Sankaran et al68Grinyó et al69 | IL10 | An immunomodulatory cytokine with anti-inflammatory effects | rs1800896 | Increased acute kidney allograft rejection |
Alakulppi et al67Sankaran et al68Grinyó et al69Sánchez-Fructuoso et al91 | TNF-α | Proinflammatory cytokine | rs1800629 | (rs1800629 in Donor and Recipient)Increased acute kidney allograft rejection episodes(rs1800629 in Recipient)Modulates the effect of ATG treatment |
Tinckam et al70Hueso et al165 | TGF-β | Anti-inflammatory but profibrotic cytokine | rs1982073rs1800471 | Reduced risk of late acute kidney allograft rejections with rs1800471 and increased kidney allograft subclinical rejection with rs1982073 |
Pawlik et al71 | CD 28 | A costimulatory molecule involved in T cell-mediated immune response | rs3116496 | Increased acute kidney allograft rejection |
Golshayan et al72 | MBL2 | Complement-activating MBL, a soluble pattern recognition receptor | rs7096206 rs5030737 rs1800450 rs1800451 | Increased acute kidney allograft rejection |
Canossi et al63 | CTLA4 | CTLA4 transduces signals that inhibit lymphocyte activation | rs231775 rs3087243 | Reduced acute kidney allograft rejection with rs231775 and increased acute kidney allograft rejection with rs3087243 |
Heidenreich et al74 | Factor II | Prothrombotic factor | rs1799963 | Increased acute kidney allograft rejection, especially vascular rejections, and early allograft failure |
Heidenreich et al74 | Factor V Leiden | Prothrombotic factor | rs6025 | Increased acute kidney allograft rejection especially vascular rejections |
Heidenreich et al74 | MTHFR | Prothrombotic factor | rs1801133 | Increased acute kidney allograft rejection, especially vascular rejections |
Cartron et al96 | FCGR3A | Encodes the IgG Fc receptor | rs396991 | Increased risk of infection following Rituximab in recipients of liver transplant |
The panel is not exhaustive of all published literature.
ABCB1, ATP binding cassette subfamily B member 1; ApoL1, Apolipoprotein 1; ATG, antithymocyte globulin; CAV1, caveolin-1; CCR, chemokine receptor; CMV, cytomegalovirus; CTLA, cytotoxic T-lymphocyte antigen; IFN-γ, interferon-gamma; IL2RB, IL2 Receptor Beta; MBL, mannose-binding lectin; MICA, MHC class I-related chain A; MiR, microRNA; MTHFR, methylenetetrahydrofolate reductase; NLRP3, NOD-like receptor family, pyrin domain containing 3; SNP, single nucleotide polymorphism; TGF, transforming growth factor; TLR, Toll-Like Receptor; TNF-α, tumor necrosis factor-alpha; Treg, regulatory T cells.